Monitor DGX's leverage ratios and upcoming debt maturities. The 5% coupon is unremarkable for an A-rated issuer. No near-term equity catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 11 $189.81entry
- T+1 · 6mo ago +0.19%α +0.33% · $190.18
- T+5 · 6mo ago +0.02%α +0.10% · $189.84
- T+20 · 5mo ago +7.76%α +8.06% · $204.53
- T+60 · 3mo ago +24.25%α +19.86% · $235.84
Price Chart
How similar events traded
Executive Summary
Quest Diagnostics issued $500M of 5.000% senior notes due 2036, a routine debt refinancing/capital raise. The notes are senior unsecured obligations and rank equally with existing debt. The filing has no impact on equity fundamentals or operations.
Key Facts
- Issued $500,000,000 aggregate principal of 5.000% senior notes due 2036.
- Interest payable semi-annually on June 30 and December 30, starting December 30, 2026.
- Notes mature on June 30, 2036.
- Notes are senior unsecured obligations, ranking equally with existing and future senior unsecured debt.
- Upon a change of control triggering event, holders may require repurchase at 101% of principal plus accrued interest.
Financial Impact
No impact on revenue, earnings, or cash flow. Increases long-term debt by $500M with 5% fixed coupon.
Risk Factors
- Higher interest expense (approx. $25M annually) could modestly pressure net income.
- Increased leverage may limit financial flexibility for future acquisitions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-057938 |
| Document: tm2613096d2_ex5-1.htm | 0001104659-26-057938 |
| Document: tm2613096d2_8k.htm | 0001104659-26-057938 |
| Document: 0001104659-26-057938-index-headers.html | 0001104659-26-057938 |
| Document: 0001104659-26-057938-index.html | 0001104659-26-057938 |
| Document: 0001104659-26-057938.txt | 0001104659-26-057938 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $259.60 +0.00% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $259.60 +0.35% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $259.60 +0.45% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $259.60 +1.55% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $259.60 +5.69% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers